« Previous article
New SARS-CoV-2 Rapid...

23rd November 2020  Content supplied by: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 24 Nov 2020


This week: 'Just in time' or just too late - FDA authorizes advanced molecular test you can perform at home based on loop-mediated amplification technology; India Medical Council gets behind affordable CRISPR test that can be read on a simple paper strip; ECDC releases document on rapid antigen tests urging member nations to get validating; a promising T-cell detection method to show a previous infection with SARS-CoV-2 to be released this fall and Cytiva offers an immunoassay development service. 

US FDA Authorizes First At-Home Molecular COVID-19 Test 

US FDA Authorizes First At-Home Molecular COVID-19 Test 

The US FDA has authorized the first prescription COVID-19 molecular test that can be performed entirely at-home. The test fits into the palm of your hand and uses real-time LAMP technology to give a result in just 11 minutes. 
Find Out More

 

Urgent Demand From ECDC to Validate COVID-19 Rapid Antigen Tests

Urgent Demand From ECDC to Validate COVID-19 Rapid Antigen Tests

The ECDC has revised its recommendations for rapid antigen testing in a new document that provides independent evaluations of several rapid antigen tests on the market along with requirements labs must adhere to. 
Find Out More

 

New Point-of-Care Immunoassay Development Service 

New Point-of-Care Immunoassay Development Service 

Cytiva (Formerly GE Healthcare) has started a new diagnostic test development and support service for point-of-care diagnostic developers to increase speed to market of new tests through infrastructure, expertise and consultation for immunoassay development.
Find Out More

 

Microsoft and Biotech Pair-Up to Design New T-Cell Test For SARS-CoV-2 Infection

Microsoft and Biotech Pair-Up to Design New T-Cell Test For SARS-CoV-2 Infection

A new clinical diagnostic test that measures the T-cell response in SARS-CoV-2 infected individuals that can provide a complete picture of the duration of immunity to the virus following an infection or administration of a vaccine will be released this fall. 
Find Out More

 

CRISPR Dipstick Test for COVID-19 Diagnosis is Rolled Out

CRISPR Dipstick Test for COVID-19 Diagnosis is Rolled Out

Tata Group has begun distributing its Feluda COVID-19 test to labs across India. The CRISPR-based test utilizes a specially adapted Cas9 protein transcription, and a result is read on a dipstick placed into the CRISPR mixture after amplification of the viral material. 
Find Out More

 

Recombinant Version of Mink Strain Spike-Protein Available 

Recombinant Version of Mink Strain Spike-Protein Available 

Sino Biological has launched a recombinant Y453F RBD protein, the mutation in SARS-CoV-2 that infected mink and workers at a farm in Denmark recently. This protein adds to Sino's large collection of proteins for antibody and vaccine research. 
Find Out More


    

Tags:

Date Published: 23rd November 2020


View full company details




rapidmicrobiology.com

Address:

Cork

Ireland

Tel: +[353] 23 88 31884

Email Supplier

View full company details


Related news from rapidmicrobiology.com